Mechanism of Roux-en-Y Gastric Bypass Treatment for Type 2 Diabetes in Rats

Journal of Gastrointestinal Surgery

Volumn 17, Issue 6, 2013, Pages 1073-1083

  Yu, Hongwei ^a   Zheng, Xiyan ^a   Zhang, Zongming ^a,b  

^a Tsinghua University   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Beta cells; Gene expression profile; Insulin; Islets; Roux en Y gastric bypass

Indexed keywords

CALCIUM; CALCIUM CHANNEL; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; RNA; TRANSCRIPTOME;

ANIMAL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; DNA MICROARRAY; GENETICS; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PATHOLOGY; RAT; STOMACH BYPASS; WISTAR RAT;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RATS; RATS, WISTAR; RNA; TRANSCRIPTOME;

EID: 84877782025     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-013-2188-3     Document Type: Article

References (40)

1. Shaw JE, Sicree RA, Zimmet PZ (2010) Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 87: 4-14.
2. Dixon JB, Zimmet P, Alberti KG, Mbanya JC, Rubino F. Bariatric surgery for diabetes: the international diabetes federation takes a position. J Diabetes 2011;3: 261-264.
3. Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care 2007;30: 162-172.
4. Obeid F, Falvo A, Dabideen H, Stocks J, Moore M, Wright M. Open Roux-en-Y gastric bypass in 925 patients without mortality. Am J Surg 2005;189: 352-356.
5. Hubens G, Balliu L, Ruppert M, Gypen B, Van TT, Vaneerdeweg W. Roux-en-Y gastric bypass procedure performed with the da Vinci robot system: is it worth it? Surg Endosc 2008;22: 1690-1696.
6. Gass M, Beglinger C, Peterli R. Metabolic surgery-principles and current concepts. Langenbecks Arch Surg 2011;396: 949-972.
7. Laferrere B. Do we really know why diabetes remits after gastric bypass surgery? Endocrine 2011;40: 162-167.
8. Alfonso T, Rami L, Naji A, William O. R. Is Roux-en-Y Gastric Bypass Surgery the Most Effective Treatment for Type 2 Diabetes Mellitus in Morbidly Obese Patients? J Gastrointest Surg 2005;9: 1112-1118.
9. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabetic Med 2011;28: 628-642.
10. 2(LBMI). Obes Surg 2009;19: 307-312.
11. Mistry SB, Omana JJ, Kini S. Rat models for bariatric surgery and surgery for type 2 diabetes mellitus. Obes Surg 2009;19: 655-660.
12. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 1976;119: 85-90.
13. Marion LV, Serena C, Michael RR, Nayyar I. Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus. Ann Intern Med 2009;150: 94-103.
14. Rubino F, Gagner M, Gentileschi P. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004;240: 236-242.
15. Ashrafian H, Athanasiou T, Li JV, Bueter M, Ahmed K, Nagpal K, Holmes E, Darzi A, Bloom S R. Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass. Obesity Reviews 2011;12: e257-e272.
16. de Haan BJ, Faas MM, Spijker H, van Willigen JW, de Haan A, de Vos P. Factors influencing isolation of functional pancreatic rat islets. Pancreas 2004;29: e15-e22.
17. Al-Mashat HA, Kandru S, Liu RK, Behl Y, Desta T, Graves DT. Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes 2006;55: 487-495.
18. 2+-calmodulin signals in nucleus and cytosol. Curr Biol 2000;10: 86-94.
19. Barg S, Galvanovskis J, Gopel SO, Rorsman P, Eliasson L. Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 2000;49: 1500-1510.
20. Zhang ZY, Pan LJ, Zhang ZM. Functional interactions among STIM1, Orail and TRPC1 on the activation of SOCs in HL-7702 cells. Amino acids 2010;39: 195-204.
21. Butler AE, Janson J, Soeller WC, Butler PC. Increased-cell apoptosis prevents adaptive increase in-cell mass in mouse model of Type 2 Diabetes evidence for role of islet amyloid formation rather than direct action of amyloid. Diabetes 2003;52: 2304-2314.
22. 2+ oscillation. Biophys J 1994;67: 447-456.
23. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene Ontology: tool for the unification of biology. Nat Genet 2000;25: 25-29.
24. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signaling. Nat Rev Mol Cell Biol 2000;1: 11-21.
25. Bootman MD, Collins TJ, Peppiatt CM, Prothero LS, MacKenzie L, De Smet P, Travers M, Tovey SC, Seo JT, Berridge MJ, Ciccolini F, Lipp P. Calcium signalling: an overview. Semin Cell Dev Biol 2001;12: 3-10.
26. Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg 2001;25: 527-531.
27. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJW. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005;310: 996-999.
28. Ikeda Y, Suehiro T, Nakamura T, Kumon Y, Hashimoto K. Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr J 2001;48: 81-86.
29. Ukkola O. Gastric bypass and glucose metabolism. Intern Med J 2009;39: 502-505.
30. Thaler JP, Cummings DE. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009;150: 2518-2525.
31. Engstrom BE, Burman P, Holdstock C, Karlsson FA. Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 2003;88: 5193-5198.
32. Kojima M, Hosoda H, Date Y, Tonon MC, Chartrel N, Cortes CL. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999;402: 656-660.
33. Meijer RI, van Wagensveld BA, Siegert CE, Eringa EC, Serne EH, Smulders YM. Bariatric surgery as a novel treatment for Type 2 Diabetes Mellitus. Arch Surg 2011;146: 744-750.
34. José MR, Silvia S, Xenia C, Sonia P, Albert G, David B, Lourdes T, Manuel P, Luis G. Effect of Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy on Glucose and Gut Hormones: a Prospective Randomised Trial. J Gastrointest Surg 2012;16: 1116- 1122.
35. De Block CE, van Gaal LF. GLP-1 receptor agonists for type 2 diabetes. Lancet 2009;374: 4-6.
36. 2+ microdomains and the control of insulin secretion. Cell Calcium 2006;40: 539-551.
37. Hao MM, Li X, Rizzo MA, Rocheleau JV, Dawant BM, Piston DW. Regulation of two insulin granule populations within the reserve pool by distinct calcium sources. J Cell Sci 2005;118: 5873-5884.
38. 2+ depletion from granules inhibits exocytosis. A study with insulin-secreting cells. J Biol Chem 1998;273: 19002-19008.
39. Worley JF, McIntyre MS, Spencer B, Mertz RJ, Roe MW, Dukes ID. Endoplasmic reticulum calcium store regulates membrane potential in mouse islet beta-cells. J Biol Chem 1994;269: 14359-14362.
40. 2+ dynamics of isolated mouse β-cells and islets: implications for mathematical models. Biophys J 2003;84: 2852-2870.